Rentokil Initial (LON:RTO – Get Rating)‘s stock had its “outperform” rating reissued by equities researchers at Royal Bank of Canada in a research note issued on Thursday, MarketBeat Ratings reports. They currently have a GBX 645 ($7.77) target price on the stock. Royal Bank of Canada’s target price indicates a potential upside of 22.07% from the company’s current price.
A number of other brokerages have also recently issued reports on RTO. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and issued a GBX 600 ($7.23) price target on shares of Rentokil Initial in a research note on Thursday, November 3rd. JPMorgan Chase & Co. restated an “overweight” rating and set a GBX 650 ($7.83) target price on shares of Rentokil Initial in a research note on Tuesday, October 11th. Finally, Shore Capital restated an “overweight” rating on shares of Rentokil Initial in a research note on Monday, November 14th. One analyst has rated the stock with a hold rating and seven have given a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of GBX 632.14 ($7.62).
Rentokil Initial Stock Performance
Shares of Rentokil Initial stock opened at GBX 528.40 ($6.37) on Thursday. The stock has a market cap of £13.32 billion and a price-to-earnings ratio of 3,775.71. The firm’s 50-day moving average is GBX 531.57 and its 200 day moving average is GBX 518.21. Rentokil Initial has a 1 year low of GBX 441.20 ($5.32) and a 1 year high of GBX 565.40 ($6.81). The company has a debt-to-equity ratio of 264.09, a current ratio of 1.88 and a quick ratio of 1.76.
Rentokil Initial Company Profile
(Get Rating)
Rentokil Initial plc, together with its subsidiaries, provides route-based services in North America, the United Kingdom, the rest of Europe, Asia, the Pacific, and internationally. It offers a range of pest control services for rodents, and flying and crawling insects, as well as other forms of wildlife management for commercial and residential customers.
read more
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider Rentokil Initial, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Rentokil Initial wasn’t on the list.
While Rentokil Initial currently has a “Moderate Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Comments are closed.